That blog is old news and was discussed on these threads in...

That blog is old news and was discussed on these threads in August last year and some investors actually sold out at 2 or 3 cents because of it.

It has since been proven absolutely baseless. The blogs credibility has taken a hammering.

There is no competition. RAP is the only cough app with an FDA application and who has conducted successful clinical trials. The tele health companies haven't tied into any other cough app. There all waiting for RAP to get FDA approval.

More accurate than a stethoscope and an x ray and after the last announcement ResApp is the only method able to seperate bacterial and atypical pneumonia from viral pneumonia and with incredible accuracy of 89% and 92% respectively (and this accuracy will only increase with more testing).

I am sure Tony Keating will hammer home the great progress RAP has made in the next few days of TechKnow presentations.

Looks like the bottom was in today.